The Prostate Cancer Registry: First results from an international, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)

被引：1
|
作者：
Chowdhury, S. [1 ]
Birtle, A. J. [2 ]
Bjartell, A. [3 ]
Costa, L. [4 ,5 ]
Feyerabend, S. [6 ]
Galli, L. [7 ]
Lumen, N. [8 ]
Kalinka-Warzocha, E. [9 ]
Maroto, P. [10 ]
Matveev, V. B. [11 ]
Paiss, T. [12 ]
Spaeth, D. [13 ]
Klumper, E. [14 ]
Thingstad, T. [15 ]
Wapenaar, R. [16 ]
Lee, E. [17 ]
机构：
[1] Guys Hosp, Dept Urol, London SE1 9RT, England
[2] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England
[3] Skane Univ Hosp, Dept Urol, Malmo, Sweden
[4] Hosp Santa Maria, Lisbon, Portugal
[5] Univ Lisbon, Inst Med Mol, P-1699 Lisbon, Portugal
[6] Studienpraxis Urol, Nurtingen, Germany
[7] Azienda Osped Univ Pisana, Med Oncol, Pisa, Italy
[8] Ghent Univ Hosp, Dept Urol, Ghent, Belgium
[9] Wojewodzki Szpital Specjalistyczny Im M Kopernika, Lodz, Poland
[10] St Pau Hosp, Barcelona, Spain
[11] NN Blokhin Canc Res Ctr, Dept Oncourol, Moscow, Russia
[12] Urol Team Ulm, Ulm, Germany
[13] Ctr Oncol Gentilly, Nancy, France
[14] SMS Oncol BV, Amsterdam, Netherlands
[15] Janssen Cilag AS, Oslo, Norway
[16] Janssen Cilag BV, Tilburg, Netherlands
[17] Janssen Pharmaceut, EMEA Med Affairs, B-2340 Beerse, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31367-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2548
引用
收藏
页码：S492 / S492
页数：1
相关论文
共 50 条
  • [31] CYCLONE 1: abemaciclib in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)
    Agarwal, Neeraj
    Guana, Daniel Castellano
    Gordoa, Teresa A.
    Arija, Jose A.
    Colomba, Emeline
    Gravis, Gwenaelle
    Mourey, Loic
    Oudard, Stephanie
    Flechon, Aude
    Gonzalez, Macarena
    Maroto-Rey, Pablo
    Schweizer, Michael
    Gallardo, Enrique
    Nacerddine, Karim
    Appiach, Adams K.
    Balar, Arjun
    Johnston, Erica
    Piulats, Jose M.
    CANCER RESEARCH, 2023, 83 (08)
  • [32] DNA REPAIR GENE DEFECTS IN AUSTRALIAN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Banks, Patricia
    Leong, Huei San
    Ryland, Georgie
    Beshay, Victoria
    Tran, Ben
    Toner, Guy
    Murphy, Declan
    Fox, Stephen
    Weickhardt, Andrew
    Pezaro, Carmel
    Thorne, Heather
    Goode, David
    Fellowes, Andrew
    Sandhu, Shahneen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 58 - 58
  • [33] DNA repair gene defects in Australian men with metastatic castration-resistant prostate cancer (mCRPC)
    Banks, Patricia
    San Leong, Huei
    Ryland, Georgina
    Beshay, Victoria
    Tran, Ben
    Toner, Guy
    Murphy, Declan
    Fox, Stephen
    Weickhardt, Andrew
    Pezaro, Carmel
    Thorne, Heather
    Goode, David
    Fellowes, Andrew
    Sandhu, Shahneen
    BJU INTERNATIONAL, 2017, 120 : 8 - 8
  • [34] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [35] A real-world registry of patients with metastatic castration-resistant prostate cancer (mCRPC): REMPRO study.
    Gonzalez, Francisco
    Kodagali, Rohit
    Tung, Teresa
    Masoud, Mohamed
    Rajadhyaksha, Viraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [36] A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE
    Payne, Heather
    Robinson, Angus
    Rappe, Bernard
    Hilman, Serena
    De Giorgi, Ugo
    Joniau, Steven
    Bordonaro, Roberto
    Mallick, Stephane
    Dourthe, Louis-Marie
    Flores, Moises Mira
    Guma, Josep
    Baron, Benoit
    Duran, Aurea
    Pranzo, Alessandra
    Serikoff, Alexis
    Mott, David
    Herdman, Mike
    Pavesi, Marco
    De Santis, Maria
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (05) : 837 - 846
  • [37] A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC)
    Aggarwal, R. R.
    Vuky, J.
    VanderWeele, D.
    Rettig, M.
    Heath, E.
    Nasoff, M.
    Dorr, A.
    Liu, B.
    Small, E. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S639 - S639
  • [38] THE EFFECTIVENESS AND SAFETY OF CABAZITAXEL (CBZ) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN ROUTINE CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)
    Carles, Joan
    Katolicka, Jana
    Korunkova, Hana
    Tomova, Antoaneta
    Ghosn, Marwan
    El Karak, Fadi
    Makdessi, Joseph
    Koroleva, Irina
    Ozatilgan, Ayse
    Hitier, Simon
    Pichler, Angelika
    JOURNAL OF UROLOGY, 2018, 199 (04): : E700 - E700
  • [39] Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer
    Barata, Pedro C.
    Assayag, Jonathan
    Li, Benjamin
    Siu, Gordon
    Niyazov, Alexander
    JAMA ONCOLOGY, 2024, 10 (07) : 975 - 977
  • [40] Randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC)
    Kim, Joseph W.
    McKay, Rana R.
    Taplin, Mary-Ellen
    Davis, Nancy B.
    Monk, Paul
    Appleman, Leonard Joseph
    Lara, Primo
    Vaishampayan, Ulka N.
    Zhang, Jingsong
    Paul, Asit K.
    Bubley, Glenn
    Van Allen, Eliezer Mendel
    Huang, Ying
    Zhang, Zhenwei
    Loda, Massimo
    Shapiro, Geoffrey
    LoRusso, Patricia
    Ivy, S. Percy
    Petrylak, Daniel Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345